Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Nancy Dawson, MD, shares her impressions of the LATITUDE study

Dr. Dawson, Professor of Medicine, Lombardi Cancer Center, Georgetown University Hospital, offers opinion on the LATITUDE study presented at ASCO 2017

Tags: ASCO Conference Coverage

Published: 08 June 2017

Recent Videos

video

Hani Babiker, MD, elaborates on tumor treatment fields applying to GI malignancies

Dr. Babiker, Assistant Director, University of Arizona Cancer Center, explains how treatment fields apply to gastrointestinal malignancies

video

Hani Babiker, MD, describes the setting of FDA approval on tumor treatment fields

Dr. Babiker, Assistant Director, University of Arizona Cancer Center, describes the setting of FDA approval on tumor treatment fields

video

Ahmed Kaseb, MD, on combining cabozantinib with checkpoint inhibitors for treatment of HCC

Dr. Kaseb, Department of Gastrointestinal Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, discusses the combination of cabozantinib ...

video

Ahmed Kaseb, MD, on survival outcomes in the IMBRAVE 150 phase 3 study

Dr. Kaseb, Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, on the survival outcomes in ...

video

Nevena Damjanov, MD, on impressions of the study of cabozantinib with in HCC patients

Dr. Damjanov, Director of Gastrointestinal Oncology, University of Pennsylvania, on her impressions of the study presented at ASCO which combines ...

video

Nevena Damjanov, MD, elaborates on the role of TKIs in managing 2nd line HCC patients

Dr. Damjanov, Director of Gastrointestinal Oncology, University of Pennsylvania, discusses her thoughts on the role of TKIs in managing 2nd ...

video

Nevena Damjanov, MD, tells us about the outcomes of combining atezolizumab with bevacizumab

Dr. Damjanov, Director of Gastrointestinal Oncology, University of Pennsylvania, tells us about the outcomes of combining atezolizumab with bevacizumab in ...

video

Eileen O'Reilly, MD, on the phase 2 study comparing chemo with or without veliparib in pancreas

Dr. O'Reilly, Winthrop Rockefeller Endowed Chair in Medical Oncology, Memorial Sloan Kettering Center, shares perspective on the phase 2 study ...

video

Eileen O'Reilly, MD, provides evidence to inform treatment of pancreatic cancer patients

Dr. O'Reilly, Winthrop Rockefeller Endowed Chair in Medical Oncology, Memorial Sloan Kettering Cancer Center, provides evidence to inform treatment and ...

video

Sam Klempner, MD, explains how circulating tumor DNA can be used to help determine therapy

Dr. Klempner, Assistant Professor of Medicine, Harvard Medical School, explains how circulating tumor DNA can be used as a diagnostic ...

Related Videos

video-image

Ahmed Kaseb, MD, on survival outcomes in the IMBRAVE 150 phase 3 study

video-image

Daniel Catenacci, MD, discusses margetuximab in the treatment of esophageal and gastric cancer

video-image

Ahmed Kaseb, MD, on combining cabozantinib with checkpoint inhibitors for treatment of HCC

video-image

Hani Babiker, MD, describes the setting of FDA approval on tumor treatment fields

video-image

Nevena Damjanov, MD, tells us about the outcomes of combining atezolizumab with bevacizumab

video-image

Hani Babiker, MD, elaborates on tumor treatment fields applying to GI malignancies

video-image

Eileen O'Reilly, MD, on the phase 2 study comparing chemo with or without veliparib in pancreas

video-image

Manish Shah, MD, regarding the use of liquid biopsy to diagnose and treat GI cancers

video-image

Nevena Damjanov, MD, on impressions of the study of cabozantinib with in HCC patients

video-image

Manish Shah, MD, on the role of Cyramza in the treatment of gastric and esophageal cancers

video-image

Nevena Damjanov, MD, elaborates on the role of TKIs in managing 2nd line HCC patients

video-image

Daniel Catenacci, MD, elaborates on the outcomes of the JAVELIN 100 study presented at ASCO GI 2020

video-image

Sam Klempner, MD, explains how circulating tumor DNA can be used to help determine therapy

video-image

Eileen O'Reilly, MD, provides evidence to inform treatment of pancreatic cancer patients

video-image

Amer Zeidan, MBBS, speculates on the role of immune checkpoint blockades in myeloid malignancies

video-image

Richard Stone, MD, provides opinion on whether all AML patients should be tested for FLT3 mutations

video-image

Frederick Locke, MD, provides his impression of the Transcend-NHL study from ASH 2019

video-image

Peter M. Voorhees, MD, shares the current thinking regarding treatment algorithms in MM

video-image

Richard Stone, MD, describes the landscape of mutations and targeted therapy in AML

video-image

Richard Stone, MD, on how oral HMA agents may impact the treatment landscape in myeloid malignancies